Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mickael Soletchnik

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
British Journal of Clinical Pharmacology|May 17, 2022
Central anticholinergic syndrome secondary to atropine eye drops: A case studyMickael Soletchnik, Geoffroy Rousseau, Lola Gonzalez, et al.
Revue De L'Infirmiere|September 23, 2022
[Path of a fighter]Mickael Soletchnik, Fabienne Vacher-Godet, Nicolas Bounaud, et al.
European Journal of Hospital Pharmacy : Science and Practice|September 11, 2020
Observational study on off-label use of tocilizumab in patients with severe COVID-19Laetitia Albertini, Mickael Soletchnik, Anais Razurel, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
British Journal of Clinical Pharmacology|May 17, 2022
Central anticholinergic syndrome secondary to atropine eye drops: A case studyMickael Soletchnik, Geoffroy Rousseau, Lola Gonzalez, et al.
Revue De L'Infirmiere|September 23, 2022
[Path of a fighter]Mickael Soletchnik, Fabienne Vacher-Godet, Nicolas Bounaud, et al.
European Journal of Hospital Pharmacy : Science and Practice|September 11, 2020
Observational study on off-label use of tocilizumab in patients with severe COVID-19Laetitia Albertini, Mickael Soletchnik, Anais Razurel, et al.
Pageof 1